Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade
Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade
Background
Persistent infection with Human Papillomavirus (HPV) type 16 causes the majority of cervical cancers. Genital HPV infection is very common, but neoplastic progression is uncommon. There is an urgent need to identify biomarkers associated with cervical neoplasia that can be used to triage women who test positive for HPV.
Objectives
To assess the ability of quantitative measurement of HPV16 DNA methylation to separate samples of different cytology grades and cervical cancers, and determine which of the assessed regions of the HPV genome and individual CpGs are most informative.
Study design
DNA methylation was quantified by pyrosequencing of bisulphite converted DNA from liquid based cytology samples from 17 women with normal cytology and 20 women with severe dyskaryosis, and from fixed tissue from 24 women with cervical cancer. Methylation was assessed in the HPV Long Control Region (LCR), E2 and L1/L2 regions.
Results
In cervical cancers, increased HPV DNA methylation was present in all regions. Increased methylation was also observed in severely dyskaryotic relative to normal samples, but only in the E2 and L1/L2 regions. The ability of methylation based classifiers to separate the three classes of material was assessed by ROC curve analyses. The best separation between normal and dyskaryotic samples was achieved by assessment of the L1/L2 CpGs at nucleotide positions 5600 and 5609 (AUC = 0.900, 95% CI: 0.793–1).
Conclusions
This study demonstrates the potential of quantification of HPV DNA methylation as a biomarker of cervical neoplasia. An algorithm considering methylation at specific L1/L2 CpGs appeared the most promising model.
24 - 29
Bryant, D.
10ed83e8-8080-4d9c-bba5-df9d4eec3a10
Tristram, Amanda
9962ca8f-c4d6-476d-bef0-bb9249ccc7f8
Liloglou, T.
09cdd0ca-3b72-48f2-af54-bb608a0ba37a
Hibbitts, S.
dc5bb5c9-0925-43e8-85dd-f1f8a0ac3acc
Fiander, Alison
dcd183ce-037b-4ad2-81b6-4d91eeabdf65
Powell, Ned
c82a9b00-db84-4276-8720-fdb5a733df8d
Bryant, D.
10ed83e8-8080-4d9c-bba5-df9d4eec3a10
Tristram, Amanda
9962ca8f-c4d6-476d-bef0-bb9249ccc7f8
Liloglou, T.
09cdd0ca-3b72-48f2-af54-bb608a0ba37a
Hibbitts, S.
dc5bb5c9-0925-43e8-85dd-f1f8a0ac3acc
Fiander, Alison
dcd183ce-037b-4ad2-81b6-4d91eeabdf65
Powell, Ned
c82a9b00-db84-4276-8720-fdb5a733df8d
Bryant, D., Tristram, Amanda, Liloglou, T., Hibbitts, S., Fiander, Alison and Powell, Ned
(2013)
Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade.
Journal of Clinical Virology, 59 (1), .
(doi:10.1016/j.jcv.2013.10.029).
Abstract
Background
Persistent infection with Human Papillomavirus (HPV) type 16 causes the majority of cervical cancers. Genital HPV infection is very common, but neoplastic progression is uncommon. There is an urgent need to identify biomarkers associated with cervical neoplasia that can be used to triage women who test positive for HPV.
Objectives
To assess the ability of quantitative measurement of HPV16 DNA methylation to separate samples of different cytology grades and cervical cancers, and determine which of the assessed regions of the HPV genome and individual CpGs are most informative.
Study design
DNA methylation was quantified by pyrosequencing of bisulphite converted DNA from liquid based cytology samples from 17 women with normal cytology and 20 women with severe dyskaryosis, and from fixed tissue from 24 women with cervical cancer. Methylation was assessed in the HPV Long Control Region (LCR), E2 and L1/L2 regions.
Results
In cervical cancers, increased HPV DNA methylation was present in all regions. Increased methylation was also observed in severely dyskaryotic relative to normal samples, but only in the E2 and L1/L2 regions. The ability of methylation based classifiers to separate the three classes of material was assessed by ROC curve analyses. The best separation between normal and dyskaryotic samples was achieved by assessment of the L1/L2 CpGs at nucleotide positions 5600 and 5609 (AUC = 0.900, 95% CI: 0.793–1).
Conclusions
This study demonstrates the potential of quantification of HPV DNA methylation as a biomarker of cervical neoplasia. An algorithm considering methylation at specific L1/L2 CpGs appeared the most promising model.
This record has no associated files available for download.
More information
Accepted/In Press date: 28 October 2013
e-pub ahead of print date: 4 November 2013
Identifiers
Local EPrints ID: 495025
URI: http://eprints.soton.ac.uk/id/eprint/495025
ISSN: 1873-5967
PURE UUID: 29301ee3-7963-4148-8465-9a028f9e3a68
Catalogue record
Date deposited: 25 Oct 2024 17:01
Last modified: 12 Nov 2024 02:50
Export record
Altmetrics
Contributors
Author:
D. Bryant
Author:
Amanda Tristram
Author:
T. Liloglou
Author:
S. Hibbitts
Author:
Alison Fiander
Author:
Ned Powell
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics